BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2004
View Archived Issues
Apomorphine reported safe and effective in advanced Parkinson's disease
Read More
Good safety profile of testosterone and sildenafil in hypogonadal men with ED
Read More
Novel PAF antagonist protects eyes against alkali and light-induced damage
Read More
Potent neuron survival-promoting agent for treatment of acute and chronic brain injury
Read More
Extension of Lilly/Isis antisense drug discovery collaboration in cancer
Read More
The Medicines Company continues to progress in late-stage development programs
Read More
Roche continues progress during first quarter
Read More
Bisphosphonate YM-529 effective in arthritic inflammation
Read More
Antisense therapy for growth hormone disorders
Read More
Dendrimer therapy effective against excessive post-eye surgery scarring
Read More
Inhibition of cytokine release with JTE-607 attenuates acid-induced lung injury
Read More
Three series of inhibitors of CDK2 and other kinases presented by Schering-Plough
Read More
Ilex presents HMG-CoA reductase lowering agents and their use in bone disorders
Read More
Schering AG claims CDK inhibitors with utility in cancer and other disorders
Read More
New PDE7 inhibitors in early development at Pfizer
Read More
New 5-HT4 receptor agonists prepared and tested by Pfizer scientists
Read More
Roche describes new MAO-B inhibitors for AD and senile dementia therapy
Read More
Sumitomo discontinues SMP-140
Read More
Mayne launches Paxene in E.U.
Read More
Progression of Axonyx phase IIb trial of phenserine
Read More
Endo plans new trial in support of oxymorphone extended-release NDA
Read More
Symbollon acquires safety data from Mimetix
Read More
Biolex acquires Epicyte Pharmaceutical
Read More
Series E financing to advance MorphoChem compounds into clinic
Read More
NIH licenses rotavirus vaccine to BIOVIRx
Read More
Sanofi-Synthelabo files registration statement with SEC regarding Aventis
Read More
Malarone shows no impact on alertness and performance tasks
Read More
Eisai and Abbott amend Japanese agreement for KES-524
Read More
Duloxetine adds to efficacy of pelvic muscle training in urinary incontinence
Read More
Intranasal PT-141 demonstrates efficacy in erectile dysfunction
Read More
Rigiscan study shows TA-1790 acts more rapidly than sildenafil
Read More
Pharmacokinetics of DA-8159 favorable in healthy subjects
Read More
Baclofen reported to reduce drug use in cocaine-dependent subjects
Read More
